State Street’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8M | Buy |
|
|||||
|
2025
Q1 | $15.2M | Sell |
|
|||||
|
2024
Q4 | $16.4M | Buy |
|
|||||
|
2024
Q3 | $17M | Buy |
|
|||||
|
2024
Q2 | $9.07M | Buy |
|
|||||
|
2024
Q1 | $6.74M | Buy |
|
|||||
|
2023
Q4 | $5.99M | Buy |
|
|||||
|
2023
Q3 | $4.39M | Sell |
|
|||||
|
2023
Q2 | $5.08M | Buy |
|
|||||
|
2023
Q1 | $6.27M | Buy |
|
|||||
|
2022
Q4 | $4.72M | Buy |
|
|||||
|
2022
Q3 | $3.84M | Buy |
|
|||||
|
2022
Q2 | $5.31M | Buy |
|
|||||
|
2022
Q1 | $5.29M | Buy |
|
|||||
|
2021
Q4 | $6.55M | Buy |
|
|||||
|
2021
Q3 | $7.11M | Buy |
|
|||||
|
2021
Q2 | $3.5M | Buy |
|
|||||
|
2021
Q1 | $189K | Hold |
|
|||||
|
2020
Q4 | $201K | Buy |
|
|||||
|
2020
Q3 | $162K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $12K | Hold |
|
|||||
|
2019
Q4 | $32K | Hold |
|
|||||
|
2019
Q3 | $18K | Sell |
|
|||||
|
2019
Q2 | $90K | Sell |
|
|||||
|
2019
Q1 | $2.06M | Sell |
|
|||||
|
2018
Q4 | $2.29M | Buy |
|
|||||
|
2018
Q3 | $5.51M | Buy |
|
|||||
|
2018
Q2 | $3.64M | Buy |
|
|||||
|
2018
Q1 | $69K | Buy |
|
|||||
|
2017
Q4 | $66K | Sell |
|
|||||
|
2017
Q3 | $83K | Buy |
|
|||||
|
2017
Q2 | $47K | Buy |
|
|||||
|
2017
Q1 | $41K | Buy |
|
|||||
|
2016
Q4 | $30K | Buy |
|
|||||
|
2016
Q3 | $40K | Sell |
|
|||||
|
2016
Q2 | $43K | Buy |
|
|||||
|
2016
Q1 | $50K | Sell |
|
|||||
|
2015
Q4 | $57K | Sell |
|
|||||
|
2015
Q3 | $208K | Buy |
|